1. Home
  2. CQP vs KVUE Comparison

CQP vs KVUE Comparison

Compare CQP & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheniere Energy Partners LP

CQP

Cheniere Energy Partners LP

N/A

Current Price

$63.48

Market Cap

32.3B

Sector

Utilities

ML Signal

N/A

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.53

Market Cap

34.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CQP
KVUE
Founded
2003
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Specialty Chemicals
Sector
Utilities
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.3B
34.2B
IPO Year
2006
2023

Fundamental Metrics

Financial Performance
Metric
CQP
KVUE
Price
$63.48
$17.53
Analyst Decision
Sell
Hold
Analyst Count
14
14
Target Price
★ $60.00
$19.50
AVG Volume (30 Days)
99.7K
★ 22.9M
Earning Date
10-29-2026
11-02-2026
Dividend Yield
★ 5.17%
4.83%
EPS Growth
N/A
★ 40.74
EPS
0.07
★ 0.48
Revenue
$10,758,000,000.00
★ $15,124,000,000.00
Revenue This Year
$4.67
$3.12
Revenue Next Year
$0.85
$2.38
P/E Ratio
$902.21
★ $36.15
Revenue Growth
★ 23.60
N/A
52 Week Low
$49.53
$14.02
52 Week High
$71.25
$20.13

Technical Indicators

Market Signals
Indicator
CQP
KVUE
Relative Strength Index (RSI) 45.37 39.48
Support Level $62.39 $17.11
Resistance Level $66.84 $17.88
Average True Range (ATR) 1.70 0.27
MACD -0.23 -0.00
Stochastic Oscillator 50.58 39.57

Price Performance

Historical Comparison
CQP
KVUE

About CQP Cheniere Energy Partners LP

Cheniere Energy Partners is a liquefied natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: